Stephen J. Forman's Insider Trades & SAST Disclosures
Stephen J. Forman's most recent trade in Lixte Biotechnology Holdings Inc was a trade of 5,851 Options to Purchase Common Stock done . Disclosure was reported to the exchange on March 31, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Stephen J. Forman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lixte Biotechnology Holdin... | Stephen J. Forman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 5,851 | 5,851 | - | - | Options to Purchase Common Stock | |
| Lixte Biotechnology Holdin... | Stephen J. Forman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2025 | 3,030 | 3,030 | - | - | Options to Purchase Common Stock | |
| Lixte Biotechnology Holdin... | Stephen J. Forman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 3,858 | 3,858 | - | - | Options to Purchase Common Stock | |
| Lixte Biotechnology Holdin... | Stephen J. Forman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 10,000 | 10,000 | - | - | Options to Purchase Common Stock | |
| Lixte Biotechnology Holdin... | Stephen J. Forman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 3,018 | 3,018 | - | - | Options to Purchase Common Stock | |
| Lixte Biotechnology Holdin... | Stephen J. Forman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 10,000 | 10,000 | - | - | Options to Purchase Common Stock | |
| Lixte Biotechnology Holdin... | Stephen J. Forman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 100,000 | 100,000 | - | - | Options to Purchase Common Stock | |
| Lixte Biotechnology Holdin... | Stephen J. Forman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.96 per share. | 22 Apr 2021 | 33,334 | 58,137 | - | 1.0 | 32,001 | Common Stock |
| Lixte Biotechnology Holdin... | Stephen J. Forman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 50,000 | 50,000 | - | - | Options to Purchase Common Stock | |
| Lixte Biotechnology Holdin... | Stephen J. Forman | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 30 Nov 2020 | 21,053 | 21,053 | - | - | Warrants to Purchase Common Stock | |
| Lixte Biotechnology Holdin... | Stephen J. Forman | Director | Purchase of securities on an exchange or from another person at price $ 4.75 per share. | 30 Nov 2020 | 21,053 | 37,720 | - | 4.8 | 100,002 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges